暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
美股市场个股详情
DYN 戴纳基
- 26.000
- +0.170+0.66%
收盘价 05/02 16:00 (美东)
- 26.230
- +0.230+0.88%
盘后 16:10 (美东)
22.41亿总市值-6582市盈率TTM
27.110最高价24.790最低价93.57万股成交量26.340今开25.830昨收2411.87万成交额1.69%换手率亏损市盈率(静)8617.77万总股本30.26952周最高24.55市净率14.40亿流通值6.40052周最低--股息TTM5538.91万流通股36.570历史最高--股息率TTM8.98%振幅4.300历史最低25.776平均价1股每手
全部分时
- 5日
- 日K
- 周K
- 月K
- 季K
- 年K
资金分布
单位: --
资金流向
实时日周月
暂无数据
新闻
评论
John Cox's appointment, with his vast biotech industry and rare disease commercialization experience, is viewed positively for Dyne Therapeutics. His leadership is anticipated to enhance the company's clinical programs and pipeline, and build more capabilities as Dyne continues to create stakeholder value.
Press Release: Dyne Therapeutics Announces CEO Transition 1
$戴纳基(DYN.US$ 🐂37.79~55.89 upswing might be risk free 🟢 zone
Recent insider share sale at current price raises slight concern. Lack of insider buying and low level of insider ownership over the past year do not inspire excitement about the stock.
2
The lack of recent insider transactions and low insider ownership at Dyne Therapeutics doesn't inspire confidence. Insider sales at prices above current levels could suggest contentment with lower valuations, potentially a weak sign for future stock performance.
Biotech Stock News 01/12 @ Open 🛎️📰
$戴纳基(DYN.US$ 4% Closing of public offering
$杰龙(GERN.US$ 4% Participate @ B. Riley Sec. Conf. '24
$ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS(ZEAL.US$ 2% Capital increase
$标记临床研究(XOMA.US$ 1% Arimoclomol NDA filing accepted
$Cellectar BioSciences(CLRB.US$ 1% Topline results @ conf. call
$CytomX(CTMX.US$ 0% Present @ B. Riley Sec. Conf. '24
$戴纳基(DYN.US$ 4% Closing of public offering
$杰龙(GERN.US$ 4% Participate @ B. Riley Sec. Conf. '24
$ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS(ZEAL.US$ 2% Capital increase
$标记临床研究(XOMA.US$ 1% Arimoclomol NDA filing accepted
$Cellectar BioSciences(CLRB.US$ 1% Topline results @ conf. call
$CytomX(CTMX.US$ 0% Present @ B. Riley Sec. Conf. '24
2
阅读更多
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅